Results 71 to 80 of about 600 (148)

Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol. [PDF]

open access: yesAddict Sci Clin Pract
Freet CS   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy